PT2968284T - Derivados alquilamina de harmina para promoção de crescimento ósseo - Google Patents
Derivados alquilamina de harmina para promoção de crescimento ósseoInfo
- Publication number
- PT2968284T PT2968284T PT147700520T PT14770052T PT2968284T PT 2968284 T PT2968284 T PT 2968284T PT 147700520 T PT147700520 T PT 147700520T PT 14770052 T PT14770052 T PT 14770052T PT 2968284 T PT2968284 T PT 2968284T
- Authority
- PT
- Portugal
- Prior art keywords
- amine
- alkyl
- bone growth
- promoting bone
- harmine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/02—Formic acid
- C07C53/06—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785306P | 2013-03-14 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2968284T true PT2968284T (pt) | 2021-06-28 |
Family
ID=51569593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147700520T PT2968284T (pt) | 2013-03-14 | 2014-03-14 | Derivados alquilamina de harmina para promoção de crescimento ósseo |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9540365B2 (pt) |
| EP (2) | EP3915987B1 (pt) |
| JP (1) | JP6721499B2 (pt) |
| CN (2) | CN105120863B (pt) |
| CA (1) | CA2899247C (pt) |
| DK (1) | DK2968284T3 (pt) |
| ES (2) | ES2971913T3 (pt) |
| HK (1) | HK1218259A1 (pt) |
| HR (1) | HRP20210931T1 (pt) |
| HU (1) | HUE055455T2 (pt) |
| LT (1) | LT2968284T (pt) |
| PL (1) | PL2968284T3 (pt) |
| PT (1) | PT2968284T (pt) |
| RS (1) | RS62053B1 (pt) |
| SI (1) | SI2968284T1 (pt) |
| WO (1) | WO2014153203A2 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2968284T (pt) | 2013-03-14 | 2021-06-28 | Osteoqc Inc | Derivados alquilamina de harmina para promoção de crescimento ósseo |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US20160106722A1 (en) | 2014-10-21 | 2016-04-21 | Life Plus, LLC | Human therapeutic agents |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| CN105837569B (zh) * | 2016-04-29 | 2017-12-26 | 华南农业大学 | 一种骆驼蓬碱噁唑啉类化合物及其制备方法和应用 |
| AU2018368790A1 (en) | 2017-11-20 | 2020-06-25 | Ichan School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| CA3086925A1 (en) | 2018-01-05 | 2019-07-11 | Ichan School Of Medicine At Mount Sinai | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition |
| WO2019183245A1 (en) * | 2018-03-20 | 2019-09-26 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| GB201810746D0 (en) | 2018-06-29 | 2018-08-15 | Mereo Biopharma 3 Ltd | Use of sclerostin antagonist |
| KR20210075071A (ko) * | 2018-08-14 | 2021-06-22 | 오스테오큐씨 인코포레이티드 | 피롤로-디피리딘 화합물 |
| CN113166058A (zh) * | 2018-08-14 | 2021-07-23 | 奥斯特克有限公司 | 氟β-咔啉化合物 |
| CN111773217A (zh) * | 2020-06-18 | 2020-10-16 | 中国人民解放军空军军医大学 | 骆驼蓬碱在制备防治慢性肾脏病的药物中的应用 |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2688022A (en) * | 1953-04-13 | 1954-08-31 | Searle & Co | 1-aminoalkyl-3-carbolines |
| US2767179A (en) * | 1954-02-12 | 1956-10-16 | Irwin Neisler And Company | Quaternary ammonium salts of carboline derivatives |
| US2800474A (en) * | 1956-03-26 | 1957-07-23 | Searle & Co | 9-(piperazinoalkyl) norharman derivatives |
| GB1268772A (en) | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME |
| US5324819A (en) | 1988-04-08 | 1994-06-28 | Stryker Corporation | Osteogenic proteins |
| US5344654A (en) | 1988-04-08 | 1994-09-06 | Stryker Corporation | Prosthetic devices having enhanced osteogenic properties |
| US5266683A (en) | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
| US5298852A (en) | 1988-12-22 | 1994-03-29 | Robert Bosch Gmbh | Arrangement for and method of controlling a three-phase-generator in a vehicle |
| US5656593A (en) | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
| ATE238417T1 (de) | 1991-11-04 | 2003-05-15 | Inst Genetics Llc | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
| EP0548553A1 (en) | 1991-11-25 | 1993-06-30 | Takeda Chemical Industries, Ltd. | Optically active azole compounds, their production and use |
| IT1255522B (it) | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
| TW270114B (pt) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| DE4435477A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indol- und -azaindol-derivate |
| DE4436190A1 (de) | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenierte ß-Carbolin-Derivate, Verfahren zu ihrer Herstellung und Verwendung dieser Substanzen zur Hemmung der Atmungskette |
| DE19613549A1 (de) | 1996-04-04 | 1997-10-09 | Bayer Ag | Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate |
| US5939039A (en) | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
| EP0957943B2 (en) | 1997-02-07 | 2008-11-26 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
| US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| AU4919099A (en) | 1998-07-11 | 2000-02-01 | University Of Bristol, The | Compounds having activity at imidazoline receptors |
| US6025538A (en) | 1998-11-20 | 2000-02-15 | Musculoskeletal Transplant Foundation | Compound bone structure fabricated from allograft tissue |
| EP1165075A4 (en) | 1999-03-10 | 2002-04-10 | Merck & Co Inc | 6-AZAINDOLE GONADOLIBERIN ANTAGONIST COMPOUNDS |
| US20070060606A1 (en) | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
| MXPA02007981A (es) | 2000-03-15 | 2004-04-05 | Aventis Pharma Gmbh | Beta-carbolinas sustituidas con actividad que inhibe la ikb-cinasa. |
| EP1134221A1 (en) | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
| EP1209158A1 (en) | 2000-11-18 | 2002-05-29 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines |
| US20030082233A1 (en) | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
| JP2004521128A (ja) | 2001-02-23 | 2004-07-15 | ワイス | Ｂｍｐによるヒト骨髄由来ｃｄ１０５＋細胞の軟骨形成能 |
| US6949251B2 (en) | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
| TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
| CN100515504C (zh) | 2001-10-12 | 2009-07-22 | 美国英佛曼公司 | 涂层,涂布体及其制造方法 |
| JP3646167B2 (ja) | 2002-02-19 | 2005-05-11 | 独立行政法人産業技術総合研究所 | フォスフォフォリンを含む複合生体材料 |
| US7176322B2 (en) | 2002-05-23 | 2007-02-13 | Amgen Inc. | Calcium receptor modulating agents |
| WO2005084157A2 (en) | 2003-06-26 | 2005-09-15 | University Of Mississippi | Methods of treating disease through the administration of a manzamine analog or derivative |
| FI20031120A0 (fi) | 2003-07-31 | 2003-07-31 | Bci Bioabsorbable Concepts Ltd | Monifunktionaalinen implanttilaite |
| US7189263B2 (en) | 2004-02-03 | 2007-03-13 | Vita Special Purpose Corporation | Biocompatible bone graft material |
| US8071574B2 (en) | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
| EP1923929B1 (en) | 2005-09-08 | 2014-12-03 | Idemitsu Kosan Co., Ltd. | Organic electroluminescence device |
| WO2007076062A2 (en) | 2005-12-21 | 2007-07-05 | Wyeth | Protein formulations with reduced viscosity and uses thereof |
| JP5080284B2 (ja) | 2006-02-10 | 2012-11-21 | 株式会社エリナ | 骨疾患の予防及び／又は治療用医薬組成物、その組成物を含有する機能性食品、健康食品及び医薬製剤、並びに歯根−歯周組織形成促進剤 |
| WO2007097981A2 (en) * | 2006-02-16 | 2007-08-30 | Millennium Pharmaceuticals, Inc. | Alpha carbolines and uses thereof |
| WO2009029625A1 (en) * | 2007-08-27 | 2009-03-05 | Kalypsys, Inc. | 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors |
| JP5583592B2 (ja) * | 2007-11-30 | 2014-09-03 | ニューリンク ジェネティクス コーポレイション | Ｉｄｏ阻害剤 |
| US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
| DK2262808T3 (da) * | 2008-03-28 | 2013-11-04 | Altiris Therapeutics | Chemokinreceptormodulatorer |
| EP2151441A1 (en) | 2008-08-06 | 2010-02-10 | Julius-Maximilians-Universität Würzburg | Beta-carbolin-derivates as substrates for an enzyme |
| US20100063085A1 (en) | 2008-09-11 | 2010-03-11 | University Court Of The University Of Dundee | Method of treating learning impairment in down's syndrome subjects |
| WO2010036567A2 (en) * | 2008-09-25 | 2010-04-01 | Osteogenex Inc. | Harmine compounds for promoting bone growth |
| US20100173931A1 (en) | 2009-01-06 | 2010-07-08 | Osteogenex Inc. | Harmine derivatives for reducing body weight |
| US8329723B2 (en) | 2009-04-24 | 2012-12-11 | John K Buolamwini | 1-aryl- or 1-heteroaryl-pyrido[B]indoles and uses thereof in treating cancers |
| US8927570B2 (en) | 2009-04-24 | 2015-01-06 | John K. Buolamwini | 1-naphthyl-or 1-dihydroacenaphthenyl-pyrido[B]indoles and uses thereof in treating cancers |
| RU2012132429A (ru) * | 2009-12-28 | 2014-02-10 | Аудиокьюр Фарма Гмбх | Бета-карболины для лечения нарушения слуха и головокружения |
| WO2011133795A2 (en) * | 2010-04-22 | 2011-10-27 | The Brigham And Women's Hospital, Inc. | Beta-carbolines as inhibitors of haspin and dyrk kinases |
| CA2803697A1 (en) | 2010-06-25 | 2011-12-29 | Facultes Universitaires Notre Dame De La Paix | Beta carboline derivatives useful in the treatment of proliferative disorders |
| US20130165474A1 (en) | 2010-08-17 | 2013-06-27 | Travis Dunckley | Compounds that inhibit tau phosphorylation |
| CN102796124B (zh) | 2011-05-26 | 2017-06-06 | 新疆华世丹药物研究有限责任公司 | 双β‑咔啉碱类化合物、其制法和其药物组合物与用途 |
| US20130315965A1 (en) | 2012-05-15 | 2013-11-28 | OssiFi, Inc. | Harmine derivatives for promoting bone growth |
| PT2968284T (pt) * | 2013-03-14 | 2021-06-28 | Osteoqc Inc | Derivados alquilamina de harmina para promoção de crescimento ósseo |
| WO2018024643A1 (en) | 2016-08-02 | 2018-02-08 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives |
-
2014
- 2014-03-14 PT PT147700520T patent/PT2968284T/pt unknown
- 2014-03-14 EP EP21169414.6A patent/EP3915987B1/en active Active
- 2014-03-14 RS RS20210790A patent/RS62053B1/sr unknown
- 2014-03-14 ES ES21169414T patent/ES2971913T3/es active Active
- 2014-03-14 WO PCT/US2014/029582 patent/WO2014153203A2/en active Application Filing
- 2014-03-14 JP JP2016503150A patent/JP6721499B2/ja active Active
- 2014-03-14 DK DK14770052.0T patent/DK2968284T3/da active
- 2014-03-14 US US14/214,037 patent/US9540365B2/en active Active
- 2014-03-14 CN CN201480015473.7A patent/CN105120863B/zh active Active
- 2014-03-14 CA CA2899247A patent/CA2899247C/en active Active
- 2014-03-14 ES ES14770052T patent/ES2875874T3/es active Active
- 2014-03-14 CN CN202110548213.8A patent/CN113416187B/zh active Active
- 2014-03-14 PL PL14770052T patent/PL2968284T3/pl unknown
- 2014-03-14 HU HUE14770052A patent/HUE055455T2/hu unknown
- 2014-03-14 LT LTEP14770052.0T patent/LT2968284T/lt unknown
- 2014-03-14 EP EP14770052.0A patent/EP2968284B1/en active Active
- 2014-03-14 SI SI201431834T patent/SI2968284T1/sl unknown
-
2016
- 2016-06-02 HK HK16106311.1A patent/HK1218259A1/zh unknown
- 2016-11-30 US US15/365,283 patent/US10501457B2/en active Active
-
2019
- 2019-10-30 US US16/668,918 patent/US11267814B2/en active Active
-
2021
- 2021-06-09 HR HRP20210931TT patent/HRP20210931T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105120863B (zh) | 2021-06-04 |
| HRP20210931T1 (hr) | 2021-09-03 |
| CA2899247A1 (en) | 2014-09-25 |
| JP6721499B2 (ja) | 2020-07-15 |
| US20140288068A1 (en) | 2014-09-25 |
| CN113416187A (zh) | 2021-09-21 |
| EP3915987C0 (en) | 2023-12-13 |
| ES2875874T3 (es) | 2021-11-11 |
| US20170298059A1 (en) | 2017-10-19 |
| JP2016519082A (ja) | 2016-06-30 |
| PL2968284T3 (pl) | 2021-09-27 |
| DK2968284T3 (da) | 2021-06-14 |
| EP2968284A2 (en) | 2016-01-20 |
| US9540365B2 (en) | 2017-01-10 |
| EP3915987B1 (en) | 2023-12-13 |
| SI2968284T1 (sl) | 2021-08-31 |
| ES2971913T3 (es) | 2024-06-10 |
| HK1218259A1 (zh) | 2017-02-10 |
| US10501457B2 (en) | 2019-12-10 |
| CN113416187B (zh) | 2024-07-19 |
| EP2968284A4 (en) | 2016-08-17 |
| HUE055455T2 (hu) | 2021-11-29 |
| CN105120863A (zh) | 2015-12-02 |
| CA2899247C (en) | 2023-04-04 |
| WO2014153203A2 (en) | 2014-09-25 |
| US20200172538A1 (en) | 2020-06-04 |
| EP3915987A1 (en) | 2021-12-01 |
| US11267814B2 (en) | 2022-03-08 |
| LT2968284T (lt) | 2021-07-12 |
| WO2014153203A3 (en) | 2014-11-13 |
| RS62053B1 (sr) | 2021-07-30 |
| EP2968284B1 (en) | 2021-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1218259A1 (zh) | 促進骨生長的烷基胺駱駝蓬碱衍生物 | |
| IL266651B (en) | graft | |
| IL243599A0 (en) | surgical implant | |
| IL240398A0 (en) | surgical implant | |
| IL240349B (en) | surgical implant | |
| IL240534A0 (en) | surgical implant | |
| EP2950303A4 (en) | PEDAL HOLDER FOR ELECTROPHONE INSTRUMENTS | |
| EP2961764A4 (en) | PROCESS FOR THE PRODUCTION OF TUBULYSINES | |
| HK1203857A1 (en) | Method for preparing biological tissue | |
| GB201322237D0 (en) | Surgical reamer | |
| SG11201505498YA (en) | Method for preparing polybutene | |
| GB201320618D0 (en) | Apparatus for robotic surgery | |
| SG11201508193TA (en) | Method for generating extended sequence reads | |
| IL269624B (en) | Production method for bromides | |
| PL3062718T3 (pl) | Implant do osteotomii | |
| KR101391404B9 (ko) | 골신장기 | |
| EP3533412C0 (en) | ENHANCED DISINTEGRABLE BONE IMPLANTS | |
| GB201313526D0 (en) | Orthopaedic Apparatus | |
| ZA201504764B (en) | Method for measuring bone loss rate | |
| HK1212353A1 (en) | Method for preparing coumestrol or coumestrin | |
| IL242897A0 (en) | A process for the preparation of pyridylpyrazole compounds and their derivatives from pyridylhydrazine | |
| GB201307817D0 (en) | Bone Growth Scaffold | |
| GB201302143D0 (en) | Bone reponator | |
| IL244646A0 (en) | Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbaldehyde | |
| ZA201405667B (en) | Growing apparatus |